Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01933321 Phase 2/Phase 3 COMPLETED

Autologous cell therapy in patients with ALS can stimulate neuroplasticity, modifying the neurodegenerative process and stops the clinical progression of disease.

Details

Lead sponsor	Hospital Universitario Dr. Jose E. Gonzalez
Phase	Phase 2/Phase 3
Status	COMPLETED
Enrolment	14
Start date	2012-09
Completion	2014-06

Conditions

• Amyotrophic Lateral Sclerosis

Interventions

• Intrathecal autologous stem cell

Primary outcomes

• Evaluation of autologous intrathecal administration of hematopoietic stem cells in patients with ALS. — up to 12 months

Countries

Mexico